Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome)

@article{Bunn1994SystemicTO,
  title={Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome)},
  author={P. Bunn and S. Hoffman and D. Norris and L. Golitz and J. Aeling},
  journal={Annals of Internal Medicine},
  year={1994},
  volume={121},
  pages={592-602}
}
Mycosis fungoides and the Sezary syndrome are low-grade, non-Hodgkin lymphomas that have a mature helper T-cell phenotype and that are always associated with cutaneous involvement [1-3]. Although they are often collectively called cutaneous T-cell lymphomas, they must be distinguished from other intermediate- and high-grade non-Hodgkin lymphomas, which may have cutaneous involvement such as peripheral T-cell lymphoma, adult T-cell leukemia-lymphoma, or B-cell non-Hodgkin lymphomas [3]. That… Expand
212 Citations
Mycosis fungoides and the Sézary syndrome.
  • 76
Treatment of Cutaneous T Cell Lymphoma
  • 51
Staging and management of cutaneous T‐cell lymphoma
  • 47
Efficacy of allogeneic hematopoietic cell transplantation in cutaneous T-cell lymphoma: results of a systematic review/meta-analysis.
  • M. Iqbal, T. Reljic, +7 authors M. Kharfan-Dabaja
  • Medicine
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2019
  • 7
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 110 REFERENCES
Treatment of cutaneous T-cell lymphoma.
  • 96
State of the art therapy of mycosis fungoides and Sézary syndrome.
  • 10
Abatement of Sézary syndrome lesions following treatment with acyclovir.
  • 7
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
  • 46
  • Highly Influential
  • PDF
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease.
  • 100
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.
  • 50
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.
  • 1,051
  • Highly Influential
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
  • 189
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma
  • 74
  • PDF
...
1
2
3
4
5
...